November 8, 2024 - November 10, 2024 : 39th Annual Meeting of the Society for Immunotherapy of Cancer
IMTXW 11.08.2024
Date of Upcoming Event:2024-11-08
Name of Upcoming Event:39th Annual Meeting of the Society for Immunotherapy of Cancer
«Back
39th Annual Meeting of the Society for Immunotherapy of Cancer
Nov 08 - Nov 10, 2024
Immatics will present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer.
Oral Presentations
Date:November 8, 2024Time:3:50 PM CSTTitle:ACTengine IMA203 TCR-T targeting PRAME shows deep and durable anti-tumor activity in heavily pretreated solid cancer patientsPresenter:Martin Wermke, M.D.Date:November 9, 2024Time:12:30 PM CSTTitle:Enhanced pharmacology data of next-generation IMA203CD8 TCR-T monotherapy targeting PRAMEPresenter:Dejka M. Araujo, M.D.
Poster Presentations
Date:November 8, 2024Poster Number: 355Title:An approach to bridging starting materials to monitor T cell persistence in adoptive T cell therapyPresenter:Jourdan Andersson, Ph.D.
Date:November 9, 2024Poster Number: 226Title:An effective donor screening program for manufacturing of allogeneic γδ T cell productsPresenter:Inbar Azoulay Alfaguter, Ph.D.
Date:November 9, 2024Poster Number: 228Title:Optimizing and streamlining the manufacturing of Vγ9Vδ2 γδ T cells for allogeneic therapyPresenter:Pooja Mehta, Ph.D.
Date:November 9, 2024Abstract Number: 360Title:Combination of a TCR-engineered autologous PRAME-targeting T cell therapy with a PRAME-encoding mRNA for the treatment of solid tumorsPresenter:Fabian Brunk, Ph.D.
Date:November 9, 2024Poster Number: 372Title:TCR-engineered T cells exhibit enhanced persistence and serial killing ability when armored with membrane-bound IL-15Presenter:Justin Gunesch, Ph.D.
Abstract:Full abstracts will be available on November 5, 2024, at 9:00 am EST in theJITCSupplement.
For more information about the presentation, read the full press release:https://investors.immatics.com/news-releases/news-release-details/immatics-announces-upcoming-oral-and-poster-presentations
Location